Contemporary validation of a SAPS 3 customized version in patients admitted to Brazilian and Uruguayan intensive care units: a multicenter cohort study

对巴西和乌拉圭重症监护病房收治患者中SAPS 3定制版进行当代验证:一项多中心队列研究

阅读:1

Abstract

OBJECTIVE: To compare the performance of the standard equation (SAPS 3-SE) and a customized version (SAPS 3-Custom) of the Simplified Acute Physiology Score 3 in a contemporary cohort of Brazilian and Uruguayan intensive care unit patients. METHODS: We conducted a retrospective cohort study of 262,198 adults admitted to 177 intensive care units between 2022 and 2023. Discrimination was assessed using the area under the Receiver Operating Characteristic curve (AUROC), and calibration by comparing predicted and observed mortality in calibration curves. RESULTS: Of patients 70% were medical, and 21% were scheduled for surgery; mean SAPS 3 was 46.6 ± 16.0. Median intensive care unit and hospital stays were 3 (1 - 5) and 8 (4 - 16) days, respectively. Intensive care unit mortality was 10.6% and hospital mortality was 16.4%. Predicted mortality was 19.0% for SAPS 3-SE and 16.6% for SAPS 3-Custom. Both models had excellent discrimination (AUROC = 0.841). SAPS 3-SE overestimated mortality across all risk deciles, whereas SAPS 3-Custom achieved uniform agreement between predicted and observed values. Standardized mortality rates were 0.86 (95%CI 0.85 - 0.87) for SAPS 3-SE and 0.98 (0.98 - 0.99) for SAPS 3-Custom; standardized resource use rates were 0.90 (0.90 - 0.91) and 0.98 (0.97 - 0.98), respectively. At the intensive care unit level, SAPS 3-Custom produced standardized mortality rates (0.95 [0.77 - 1.17]) and standardized resource use rates (0.97 [0.82 - 1.23]) distributions centered around 1.0, unlike SAPS 3-SE, which yielded lower values. Findings were consistent for medical and surgical subgroups. CONCLUSION: In this large, contemporary cohort, SAPS 3-Custom demonstrated superior calibration and accuracy over SAPS 3-SE, supporting its use for performance evaluation and benchmarking in intensive care units in Brazil and Uruguay.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。